Person- Centred Care Among Nursing Home Patients With Dementia
NCT ID: NCT01280890
Last Updated: 2012-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
624 participants
INTERVENTIONAL
2011-02-28
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Support Program for Carers of Persons With Dementia
NCT01287767
Continuing Education in Nursing Home Dementia Care
NCT01715506
Multidisciplinary Intervention for Challenging Behaviour (Agitation) in Patients With Dementia
NCT01183351
Use of Telemedicine in Collaboration Between a Psychogeriatric Unit and Nursing Homes
NCT01217268
[email protected]: Innovating the Clinical Pathway for Home Dwelling Persons With Dementia and Their Families
NCT04043364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The nursing homes will be randomized in tree groups. Group A - Applying the VIPS- framework to develop Person Centred Care (PCC) and milieu therapy. The staff will be introduced to the model for applying the VIPS-framework to promote PCC in the daily care. A manual including films with information and examples will be distributed to all staff. Two auxiliary nurses are appointed as resource persons (RP) from each ward and one registered nurse (RN) from each nursing home will be trained as coach. The RPs and the leading registered nurse (RN) will plan and lead weekly consensus meetings with the staff in the ward using the VIPS-framework in discussions of concrete care situations. The researches will receive monthly written standard reports on attendance and contents of the consensus meetings from the RPs and can be contacted for support when necessary.
Group B - using Dementia Care Mapping (DCM) developing Person Centred Care and milieu therapy All staff and leaders in the nursing home will be introduced to the DCM- process in a presentation of the method and person centred care as a value base for DCM. A group of 3-5 staff members from each nursing home will be trained as DCM basic users. Dementia Care Mappings (4-6 hours) will be made in each unit in the nursing homes and feed-back (1, 5 hours) will be given to the staff within a week after the mapping. Based on the findings and the reflections in the feed-back session, action plans on how to develop care to selected patients and/or to the group of patients, will be created in the units. The project leader will be responsible for the introduction, mapping and feed-back sessions and give the necessary supervision to create action plans. The leaders and staff in the nursing home units will be responsible for the implementation of the changes to develop practice.The DCM-process will be repeated after 6-8 months
Group C (control group) - traditional education Lectures made as 5 DVD films lasting for 30 minutes, will be given to the nursing home staff on three themes: types of dementia, legal aspects of use of restraints and challenging behavior
The staff in group A and B will receive the same lectures as the staff in the control group.
Effect will be measured on patient and staff level, and measurements will be done at baseline and after 10 months of intervention. Data will be collected by research assistants, who will not take part in the three different intervention programs and not be employed by the nursing homes that are included in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Staff training using VIPS framework
The staff will be trained to give person-centred care using the VIPS framework
Staff training using VIPS
Staff training using the VIPS framework
Staff training using DCM
Staff will be supervised in how to give person-centred care using Dementia Care Mapping
Staff training using DCM
The staff will be supervised using Dementia Care Mapping
Control group
Traditional lectures using films will be given to care staff
Control group
Filmed traditional Lectures will be given to care staff
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Staff training using VIPS
Staff training using the VIPS framework
Staff training using DCM
The staff will be supervised using Dementia Care Mapping
Control group
Filmed traditional Lectures will be given to care staff
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A score of 1,2 or 3 on the Clinical Dementia Rating Scale (CDR)
* The nursing staff in the wards where the patients are
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Research Council of Norway
OTHER
Norwegian Centre for Ageing and Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Knut Engedal, Dr.med
Role: PRINCIPAL_INVESTIGATOR
Norwegian Centre for Ageing and Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
196326/V50
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PCCNor
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.